Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free SLGN Stock Alerts

Silgan (SLGN) Financials

Silgan logo
$42.33 +1.21 (+2.94%)
As of 08/21/2026 03:58 PM Eastern
Compare
Annual Income Statements for Silgan

Annual Income Statements for Silgan

This table shows Silgan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 172 153 270 224 194 309 359 341 326 276 288
Consolidated Net Income / (Loss)		 172 153 270 224 194 309 359 341 326 276 288
Net Income / (Loss) Continuing Operations		 172 153 270 224 194 309 359 341 326 276 288
Total Pre-Tax Income 		253 232 240 293 252 407 466 474 422 348 409
Total Operating Income		 320 300 357 412 359 512 576 602 595 515 598
Total Gross Profit		 554 512 635 690 714 867 918 1,048 993 1,012 1,149
Total Revenue		 3,764 3,613 4,090 4,449 4,490 4,922 5,677 6,411 5,988 5,855 6,483
Operating Revenue		 3,764 3,613 4,090 4,449 4,490 4,922 5,677 6,411 5,988 5,855 6,483
Total Cost of Revenue		 3,210 3,101 3,455 3,759 3,776 4,055 4,759 5,364 4,996 4,843 5,334
Operating Cost of Revenue		 3,210 3,101 3,455 3,759 3,776 4,055 4,759 5,364 4,996 4,843 5,334
Total Operating Expenses		 234 212 278 278 354 355 342 446 397 497 552
Selling, General & Admin Expense		 220 220 305 308 316 378 378 417 384 438 493
Restructuring Charge		 14 19 5.83 6.25 56 16 15 74 8.41 59 61
Other Special Charges / (Income)		 - -27 -33 -37 -18 -39 -51 -45 4.33 -1.19 -1.62
Total Other Income / (Expense), net		 -67 -68 -117 -119 -107 -105 -110 -128 -173 -167 -189
Interest Expense		 67 68 117 119 107 105 110 128 173 167 189
Income Tax Expense		 80 79 -30 69 58 98 107 133 96 72 123
Other Gains / (Losses), net		 - - - - - - - 0.00 0.00 0.69 3.16
Basic Earnings per Share		 $1.41 $1.28 $2.44 $2.03 $1.75 $2.79 $3.25 $3.09 $3.00 $2.59 $2.71
Weighted Average Basic Shares Outstanding		 61.02M 119.73M 110.35M 110.60M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Diluted Earnings per Share		 $1.41 $1.27 $2.42 $2.01 $1.74 $2.77 $3.23 $3.07 $2.98 $2.58 $2.70
Weighted Average Diluted Shares Outstanding		 61.02M 119.73M 110.35M 110.60M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Weighted Average Basic & Diluted Shares Outstanding		 61.02M 119.73M 110.35M 110.60M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Cash Dividends to Common per Share		 $0.32 $0.68 $0.36 $0.40 $0.44 $0.48 $0.56 $0.64 $0.72 $0.76 $0.80

Quarterly Income Statements for Silgan

This table shows Silgan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 64 55 76 100 45 68 89 113 18 63 76
Consolidated Net Income / (Loss)		 64 55 76 100 45 68 89 113 18 63 76
Net Income / (Loss) Continuing Operations		 64 55 76 100 45 68 89 113 18 63 76
Total Pre-Tax Income 		84 73 101 125 49 88 119 149 53 84 104
Total Operating Income		 126 112 142 167 94 131 168 199 101 127 151
Total Gross Profit		 219 223 256 293 239 270 299 327 253 266 295
Total Revenue		 1,340 1,317 1,381 1,745 1,411 1,467 1,539 2,009 1,469 1,561 1,643
Operating Revenue		 1,340 1,317 1,381 1,745 1,411 1,467 1,539 2,009 1,469 1,561 1,643
Total Cost of Revenue		 1,122 1,094 1,125 1,452 1,172 1,196 1,240 1,681 1,216 1,295 1,348
Operating Cost of Revenue		 1,122 1,094 1,125 1,452 1,172 1,196 1,240 1,681 1,216 1,295 1,348
Total Operating Expenses		 92 112 114 126 145 140 132 129 152 139 144
Selling, General & Admin Expense		 97 100 108 106 124 129 122 122 120 131 127
Restructuring Charge		 -4.80 12 6.86 19 21 11 9.86 7.19 32 9.05 18
Other Special Charges / (Income)		 0.67 -0.41 -0.41 0.12 -0.49 -0.19 -0.14 -0.81 -0.49 -1.04 -1.11
Total Other Income / (Expense), net		 -42 -39 -41 -42 -46 -43 -49 -50 -48 -42 -47
Interest Expense		 42 39 41 42 46 43 49 50 48 42 47
Income Tax Expense		 19 18 24 25 4.29 21 30 36 36 22 29
Other Gains / (Losses), net		 - 0.00 0.00 0.00 - 1.16 0.56 0.78 0.67 1.20 0.98
Basic Earnings per Share		 $0.61 $0.52 $0.71 $0.94 $0.42 $0.64 $0.83 $1.06 $0.18 $0.60 $0.72
Weighted Average Basic Shares Outstanding		 106.50M 106.65M 106.84M 106.85M 106.79M 106.92M 106.99M 106.62M 105.44M 105.59M 105.68M
Diluted Earnings per Share		 $0.60 $0.52 $0.71 $0.93 $0.42 $0.63 $0.83 $1.06 $0.18 $0.60 $0.72
Weighted Average Diluted Shares Outstanding		 106.50M 107.05M 107.02M 107.14M 106.79M 107.34M 106.99M 106.80M 105.44M 105.86M 105.68M
Weighted Average Basic & Diluted Shares Outstanding		 106.50M 106.78M 106.78M 106.79M 106.79M 106.99M 106.99M 105.67M 105.44M 105.68M 105.68M

Annual Cash Flow Statements for Silgan

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -123 -75 29 19 131 206 222 -46 57 180 258
Net Cash From Operating Activities		 336 395 390 507 507 603 557 748 483 722 730
Net Cash From Continuing Operating Activities		 336 395 390 507 507 603 557 748 483 722 730
Net Income / (Loss) Continuing Operations		 172 153 270 224 194 309 359 341 326 276 288
Consolidated Net Income / (Loss)		 172 153 270 224 194 309 359 341 326 276 288
Depreciation Expense		 142 143 174 192 206 219 250 263 263 276 319
Amortization Expense		 4.16 4.14 4.26 3.77 3.46 4.54 5.57 5.46 5.37 5.47 5.53
Non-Cash Adjustments To Reconcile Net Income		 26 32 28 24 75 36 97 92 24 76 79
Changes in Operating Assets and Liabilities, net		 -9.48 62 -86 63 28 34 -155 47 -136 88 38
Net Cash From Investing Activities		 -237 -180 -1,198 -190 -230 -1,163 -976 -216 -224 -1,176 -297
Net Cash From Continuing Investing Activities		 -237 -180 -1,198 -190 -230 -1,163 -976 -216 -224 -1,176 -297
Purchase of Property, Plant & Equipment		 -237 -192 -174 -191 -231 -224 -232 -216 -227 -263 -307
Acquisitions		 -0.69 0.00 -1,024 0.00 0.00 -941 -746 -2.50 0.00 -922 0.00
Sale of Property, Plant & Equipment		 0.90 - - - - - 2.80 3.35 1.76 7.80 10
Other Investing Activities, net		 - 12 0.60 1.05 0.85 1.87 -0.82 -0.69 1.24 0.26 -0.25
Net Cash From Financing Activities		 -221 -289 837 -294 -146 760 649 -570 -211 663 -207
Net Cash From Continuing Financing Activities		 -221 -289 837 -294 -146 760 649 -570 -211 663 -207
Repayment of Debt		 -767 -865 -2,089 -1,280 -462 -1,831 -2,106 -1,120 -60 -1,147 -763
Repurchase of Common Equity		 -173 -281 -4.12 -7.83 -28 -42 -8.57 -45 -184 -9.32 -75
Payment of Dividends		 -40 -41 -40 -45 -51 -54 -62 -72 -79 -82 -86
Issuance of Debt		 740 919 2,961 1,043 400 2,681 2,685 835 12 1,977 704
Other Financing Activities, net		 19 -23 8.85 -4.13 -4.66 5.20 140 -167 99 -76 12
Effect of Exchange Rate Changes		 - 0.00 0.00 -3.70 -0.74 6.47 -7.53 -9.03 9.91 -28 33
Cash Interest Paid		 64 65 98 118 109 90 102 124 155 160 185
Cash Income Taxes Paid		 50 58 70 47 41 121 94 94 116 92 104

Quarterly Cash Flow Statements for Silgan

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 336 -334 -5.85 66 454 -470 -36 72 691 -645 -84
Net Cash From Operating Activities		 1,079 -548 21 313 936 -683 -221 341 1,294 -800 -194
Net Cash From Continuing Operating Activities		 1,079 -548 21 313 936 -683 -221 341 1,294 -800 -194
Net Income / (Loss) Continuing Operations		 64 55 76 100 45 68 89 113 18 63 76
Consolidated Net Income / (Loss)		 64 55 76 100 45 68 89 113 18 63 76
Depreciation Expense		 67 66 66 67 77 79 76 83 81 85 84
Amortization Expense		 1.34 1.35 1.35 1.35 1.43 1.41 1.20 1.29 1.62 1.63 1.40
Non-Cash Adjustments To Reconcile Net Income		 -0.58 16 11 23 26 15 13 12 38 16 25
Changes in Operating Assets and Liabilities, net		 947 -687 -133 122 786 -847 -401 131 1,155 -965 -380
Net Cash From Investing Activities		 -53 -72 -56 -61 -987 -82 -63 -81 -70 -80 -62
Net Cash From Continuing Investing Activities		 -53 -72 -56 -61 -987 -82 -63 -81 -70 -80 -62
Purchase of Property, Plant & Equipment		 -53 -75 -56 -61 -71 -83 -73 -80 -71 -82 -64
Sale of Property, Plant & Equipment		 0.13 2.50 0.49 0.24 4.58 0.05 9.50 0.20 0.28 2.07 2.29
Other Investing Activities, net		 -0.03 0.30 -0.25 -0.34 0.55 0.40 -0.10 -1.59 1.04 0.40 0.24
Net Cash From Financing Activities		 -699 293 36 -195 528 283 231 -188 -533 234 172
Net Cash From Continuing Financing Activities		 -699 293 36 -195 528 283 231 -188 -533 234 172
Repayment of Debt		 -845 -115 -60 -235 -709 -712 -46 -892 888 -706 -20
Payment of Dividends		 -19 -21 -20 -20 -20 -22 -21 -21 -21 -23 -22
Issuance of Debt		 5.79 598 142 63 1,174 1,111 299 786 -1,492 1,069 215
Other Financing Activities, net		 160 -161 -25 -2.01 85 -86 -1.08 -1.54 101 -99 -0.77
Effect of Exchange Rate Changes		 9.41 -6.69 - - -23 13 18 0.77 0.56 0.53 0.15
Cash Interest Paid		 31 50 41 43 27 51 53 45 37 52 40
Cash Income Taxes Paid		 20 17 27 26 22 12 33 17 42 7.88 43

Annual Balance Sheets for Silgan

This table presents Silgan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 3,193 3,149 4,645 4,579 4,931 6,512 7,771 7,346 7,611 8,585 9,397
Total Current Assets		 1,045 962 1,292 1,290 1,407 1,799 2,296 2,133 2,349 2,523 2,992
Cash & Equivalents		 100 25 54 73 204 409 631 586 643 823 1,081
Accounts Receivable		 281 288 455 511 505 620 711 658 600 594 589
Inventories, net		 628 603 721 635 633 678 799 769 941 928 1,080
Prepaid Expenses		 36 46 62 71 65 93 154 120 166 177 242
Plant, Property, & Equipment, net		 1,125 1,157 1,490 1,518 0.00 0.00 1,994 1,931 1,962 2,283 2,378
Total Noncurrent Assets		 1,022 1,030 1,864 1,772 3,524 4,712 3,481 3,282 3,301 3,779 4,027
Goodwill		 613 605 1,171 1,148 1,142 1,741 2,038 1,985 2,018 2,316 2,487
Intangible Assets		 195 181 417 383 355 637 831 764 721 869 900
Other Noncurrent Operating Assets		 214 245 275 240 2,027 2,334 612 533 561 594 640
Total Liabilities & Shareholders' Equity		 3,193 3,149 4,645 4,579 4,931 6,512 7,771 7,346 7,611 8,585 9,397
Total Liabilities		 2,553 2,680 3,879 3,698 3,908 5,259 6,208 5,628 5,722 6,595 7,123
Total Current Liabilities		 781 862 958 1,079 1,019 1,192 1,509 1,438 2,312 2,248 2,452
Short-Term Debt		 152 217 109 170 30 28 20 80 880 717 632
Accounts Payable		 477 505 660 713 727 803 1,133 974 1,076 1,112 1,252
Accrued Expenses		 107 94 124 127 195 231 246 285 258 310 447
Current Employee Benefit Liabilities		 45 46 66 69 67 130 109 99 98 109 121
Total Noncurrent Liabilities		 1,772 1,818 2,921 2,619 2,889 4,067 4,700 4,190 3,410 4,348 4,671
Long-Term Debt		 1,361 1,344 2,439 2,134 2,215 3,223 3,773 3,345 2,546 3,420 3,715
Noncurrent Deferred & Payable Income Tax Liabilities		 - 298 262 268 255 356 435 389 434 506 502
Other Noncurrent Operating Liabilities		 411 175 220 217 420 488 491 456 430 422 454
Total Equity & Noncontrolling Interests		 639 469 766 881 1,023 1,253 1,563 1,718 1,889 1,990 2,274
Total Preferred & Common Equity		 639 469 766 881 1,023 1,253 1,563 1,718 1,889 1,990 2,274
Total Common Equity		 639 469 766 881 1,023 1,253 1,563 1,718 1,889 1,990 2,274
Common Stock		 238 251 264 278 291 308 327 342 356 370 387
Retained Earnings		 1,446 1,559 1,810 1,998 2,141 2,395 2,692 2,961 3,208 3,403 3,605
Accumulated Other Comprehensive Income / (Loss)		 -209 -224 -189 -269 -260 -261 -260 -345 -251 -353 -214
Other Equity Adjustments		 - - - - - - - - -1,423 - -1,504

Quarterly Balance Sheets for Silgan

This table presents Silgan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 7,862 7,914 7,812 7,574 7,693 7,747 8,768 9,410 9,498 9,322 9,601
Total Current Assets		 2,625 2,698 2,662 2,376 2,539 2,519 2,597 3,009 3,112 2,967 3,294
Cash & Equivalents		 501 237 307 309 303 369 353 317 389 435 352
Accounts Receivable		 936 1,068 1,296 946 1,057 1,210 1,013 1,242 1,503 1,159 1,455
Inventories, net		 1,055 1,252 919 957 1,006 780 1,055 1,259 1,022 1,129 1,232
Prepaid Expenses		 133 143 140 164 173 160 176 191 198 244 256
Plant, Property, & Equipment, net		 1,930 1,934 1,912 1,944 1,934 1,956 2,303 2,382 2,393 2,355 2,335
Total Noncurrent Assets		 3,307 3,281 3,239 3,254 3,221 3,272 3,868 4,019 3,993 4,000 3,972
Goodwill		 2,002 2,007 1,980 1,997 1,987 2,024 2,373 2,485 2,481 2,465 2,457
Intangible Assets		 756 745 724 702 685 681 890 907 892 879 861
Other Noncurrent Operating Assets		 549 528 535 555 549 566 605 628 620 657 655
Total Liabilities & Shareholders' Equity		 7,862 7,914 7,812 7,574 7,693 7,747 8,768 9,410 9,498 9,322 9,601
Total Liabilities		 6,080 6,043 6,030 5,674 5,760 5,693 6,685 7,188 7,226 7,002 7,221
Total Current Liabilities		 1,844 1,880 1,916 2,289 2,396 2,306 2,285 3,135 2,451 2,358 2,590
Short-Term Debt		 785 811 898 1,346 1,398 1,254 1,145 1,937 1,135 988 1,178
Accounts Payable		 716 752 652 610 658 679 737 757 852 817 892
Accrued Expenses		 241 222 269 234 239 266 284 317 335 432 395
Current Employee Benefit Liabilities		 102 95 96 100 101 106 119 122 129 121 125
Total Noncurrent Liabilities		 4,236 4,163 4,115 3,385 3,364 3,388 4,399 4,054 4,775 4,644 4,631
Long-Term Debt		 3,370 3,351 3,313 2,535 2,531 2,554 3,483 3,115 3,812 3,672 3,656
Noncurrent Deferred & Payable Income Tax Liabilities		 389 384 380 432 425 421 487 479 511 516 521
Other Noncurrent Operating Liabilities		 477 427 422 418 408 413 429 460 452 456 455
Total Equity & Noncontrolling Interests		 1,781 1,871 1,782 1,900 1,934 2,054 2,083 2,222 2,272 2,321 2,379
Total Preferred & Common Equity		 1,781 1,871 1,782 1,900 1,934 2,054 2,083 2,222 2,272 2,321 2,379
Total Common Equity		 1,781 1,871 1,782 1,900 1,934 2,054 2,083 2,222 2,272 2,321 2,379
Common Stock		 344 347 351 358 362 366 373 376 381 391 398
Retained Earnings		 3,013 3,072 3,163 3,243 3,299 3,378 3,449 3,516 3,608 3,646 3,699
Accumulated Other Comprehensive Income / (Loss)		 -325 -280 -310 -272 -298 -261 -303 -235 -222 -206 -207
Other Equity Adjustments		 -1,251 -1,269 -1,423 -1,429 -1,429 -1,429 -1,435 -1,435 -1,495 -1,510 -1,510

Annual Metrics And Ratios for Silgan

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.78% -4.01% 13.20% 8.78% 0.92% 9.62% 15.34% 12.94% -6.60% -2.23% 10.73%
EBITDA Growth		 -9.16% -4.13% 19.78% 13.51% -6.28% 29.26% 13.04% 4.59% -0.71% -7.82% 15.83%
EBIT Growth		 -11.37% -6.28% 19.10% 15.44% -12.77% 42.53% 12.44% 4.49% -1.08% -13.49% 16.07%
NOPAT Growth		 -5.73% -9.10% 102.65% -21.64% -12.20% 40.62% 14.17% -2.46% 6.25% -11.17% 2.21%
Net Income Growth		 -5.47% -11.06% 75.84% -16.93% -13.47% 59.29% 16.31% -5.08% -4.37% -15.21% 4.35%
EPS Growth		 -50.70% -9.93% 90.55% -16.94% -13.43% 59.20% 16.61% -4.95% -2.93% -13.42% 4.65%
Operating Cash Flow Growth		 -3.58% 17.51% -1.21% 29.96% 0.16% 18.75% -7.58% 34.40% -35.52% 49.58% 1.10%
Free Cash Flow Firm Growth		 -43.25% 3.37% -448.17% 154.17% -29.47% -297.29% 71.01% 421.82% -42.47% -164.39% 181.36%
Invested Capital Growth		 -0.90% -2.26% 62.48% -4.50% -1.58% 33.64% 15.38% -3.52% 2.53% 13.49% 4.47%
Revenue Q/Q Growth		 -2.10% -0.65% 4.87% 1.71% -0.49% 3.76% 3.89% 0.25% -1.89% 1.23% 0.89%
EBITDA Q/Q Growth		 -0.83% 0.95% 10.31% -0.68% 0.31% 6.36% 4.79% -4.98% 6.93% -2.58% 1.19%
EBIT Q/Q Growth		 -2.02% -0.10% 10.60% -2.16% -1.61% 7.00% 4.29% -7.32% 8.17% -5.83% 1.17%
NOPAT Q/Q Growth		 1.73% -1.55% 84.55% -32.45% -2.67% 7.90% 6.92% -12.46% 12.41% -3.39% -8.60%
Net Income Q/Q Growth		 1.72% -1.83% 83.15% -32.52% -1.70% 8.91% 7.46% -15.06% 13.92% -6.55% -8.52%
EPS Q/Q Growth		 -48.91% 323.33% 120.00% -32.55% -1.69% 9.06% 7.31% -14.72% 14.18% -6.52% -8.16%
Operating Cash Flow Q/Q Growth		 -4.96% 6.15% -2.96% 24.36% 3.33% -4.09% 16.43% 68.15% 78.81% -16.52% 96.30%
Free Cash Flow Firm Q/Q Growth		 -36.06% 42.77% -1.91% 37.43% -26.30% -5.23% 56.11% 15.50% 2,913.15% -136.11% 120.51%
Invested Capital Q/Q Growth		 -16.10% -18.99% -7.66% -14.95% -12.52% -8.46% -11.06% -13.80% -17.80% -3.46% -18.89%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 14.72% 14.17% 15.52% 15.50% 15.90% 17.62% 16.18% 16.34% 16.58% 17.28% 17.73%
EBITDA Margin		 12.38% 12.37% 13.09% 13.66% 12.68% 14.95% 14.66% 13.57% 14.43% 13.60% 14.23%
Operating Margin		 8.50% 8.30% 8.73% 9.26% 8.01% 10.41% 10.15% 9.39% 9.94% 8.80% 9.22%
EBIT Margin		 8.50% 8.30% 8.73% 9.26% 8.01% 10.41% 10.15% 9.39% 9.94% 8.80% 9.22%
Profit (Net Income) Margin		 4.58% 4.24% 6.59% 5.03% 4.32% 6.27% 6.33% 5.32% 5.44% 4.72% 4.45%
Tax Burden Percent		 68.18% 66.12% 112.51% 76.37% 76.87% 75.84% 77.00% 71.89% 77.22% 79.49% 70.60%
Interest Burden Percent		 79.07% 77.38% 67.14% 71.17% 70.14% 79.45% 80.94% 78.77% 70.89% 67.50% 68.33%
Effective Tax Rate		 31.82% 33.88% -12.51% 23.63% 23.13% 24.16% 23.00% 28.11% 22.78% 20.70% 30.17%
Return on Invested Capital (ROIC)		 10.57% 9.77% 15.25% 9.88% 8.95% 10.86% 10.06% 9.32% 9.96% 8.19% 7.70%
ROIC Less NNEP Spread (ROIC-NNEP)		 7.29% 6.73% 8.70% 6.04% 5.08% 7.59% 7.24% 6.26% 5.20% 3.86% 3.78%
Return on Net Nonoperating Assets (RNNOA)		 14.99% 17.90% 28.40% 17.32% 11.41% 16.27% 15.45% 11.45% 8.11% 6.06% 5.83%
Return on Equity (ROE)		 25.56% 27.67% 43.65% 27.19% 20.35% 27.13% 25.51% 20.78% 18.07% 14.25% 13.53%
Cash Return on Invested Capital (CROIC)		 11.48% 12.06% -32.35% 14.48% 10.54% -17.94% -4.22% 12.91% 7.47% -4.45% 3.33%
Operating Return on Assets (OROA)		 9.89% 9.45% 9.16% 8.93% 7.56% 8.96% 8.07% 7.96% 7.96% 6.36% 6.65%
Return on Assets (ROA)		 5.33% 4.84% 6.92% 4.86% 4.08% 5.40% 5.03% 4.51% 4.36% 3.41% 3.21%
Return on Common Equity (ROCE)		 25.56% 27.67% 43.65% 27.19% 20.35% 27.13% 25.51% 20.78% 18.07% 14.25% 13.53%
Return on Equity Simple (ROE_SIMPLE)		 26.97% 32.67% 35.20% 25.42% 18.94% 24.64% 22.98% 19.84% 17.25% 13.89% 0.00%
Net Operating Profit after Tax (NOPAT)		 218 198 402 315 276 389 444 433 460 408 417
NOPAT Margin		 5.79% 5.49% 9.82% 7.07% 6.15% 7.90% 7.81% 6.75% 7.68% 6.98% 6.44%
Net Nonoperating Expense Percent (NNEP)		 3.29% 3.04% 6.55% 3.84% 3.86% 3.27% 2.82% 3.06% 4.76% 4.33% 3.92%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 8.41% 8.65% 6.67% 6.31%
Cost of Revenue to Revenue		 85.28% 85.83% 84.48% 84.50% 84.10% 82.38% 83.82% 83.66% 83.42% 82.72% 82.27%
SG&A Expenses to Revenue		 5.84% 6.09% 7.46% 6.93% 7.03% 7.67% 6.66% 6.50% 6.42% 7.49% 7.60%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 6.23% 5.87% 6.79% 6.24% 7.89% 7.21% 6.03% 6.95% 6.63% 8.48% 8.51%
Earnings before Interest and Taxes (EBIT)		 320 300 357 412 359 512 576 602 595 515 598
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 466 447 535 608 569 736 832 870 864 796 923
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.25 2.96 3.85 2.74 3.15 3.11 2.91 3.22 2.51 2.79 1.88
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.38 0.38 0.72 0.54 0.72 0.79 0.80 0.86 0.79 0.95 0.66
Price to Earnings (P/E)		 8.35 9.06 10.94 10.76 16.64 12.62 12.68 16.23 14.56 20.11 14.79
Dividend Yield		 2.68% 2.95% 1.68% 1.84% 1.51% 1.36% 1.36% 1.27% 1.62% 1.46% 1.98%
Earnings Yield		 11.98% 11.04% 9.14% 9.29% 6.01% 7.92% 7.88% 6.16% 6.87% 4.97% 6.76%
Enterprise Value to Invested Capital (EV/IC)		 1.39 1.46 1.67 1.49 1.72 1.65 1.63 1.84 1.61 1.67 1.36
Enterprise Value to Revenue (EV/Rev)		 0.76 0.81 1.33 1.04 1.17 1.37 1.36 1.31 1.26 1.52 1.16
Enterprise Value to EBITDA (EV/EBITDA)		 6.12 6.55 10.17 7.64 9.25 9.16 9.27 9.62 8.71 11.14 8.16
Enterprise Value to EBIT (EV/EBIT)		 8.92 9.76 15.25 11.27 14.65 13.15 13.39 13.91 12.65 17.23 12.60
Enterprise Value to NOPAT (EV/NOPAT)		 13.09 14.76 13.55 14.75 19.05 17.34 17.39 19.35 16.38 21.72 18.04
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.50 7.42 13.97 9.17 10.38 11.18 13.86 11.19 15.60 12.29 10.32
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.06 11.96 0.00 10.06 16.18 0.00 0.00 13.97 21.85 0.00 41.71
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 2.37 3.33 3.33 2.62 2.19 2.60 2.43 1.99 1.81 2.08 1.91
Long-Term Debt to Equity		 2.13 2.86 3.18 2.42 2.16 2.57 2.41 1.95 1.35 1.72 1.63
Financial Leverage		 2.06 2.66 3.26 2.87 2.24 2.15 2.13 1.83 1.56 1.57 1.54
Leverage Ratio		 4.79 5.72 6.31 5.60 4.99 5.03 5.07 4.61 4.15 4.18 4.22
Compound Leverage Factor		 3.79 4.43 4.24 3.99 3.50 3.99 4.11 3.63 2.94 2.82 2.88
Debt to Total Capital		 70.31% 76.89% 76.88% 72.34% 68.68% 72.18% 70.82% 66.59% 64.46% 67.52% 65.65%
Short-Term Debt to Total Capital		 7.08% 10.69% 3.28% 5.34% 0.91% 0.62% 0.38% 1.56% 16.56% 11.70% 9.54%
Long-Term Debt to Total Capital		 63.23% 66.20% 73.60% 67.00% 67.77% 71.56% 70.44% 65.04% 47.90% 55.82% 56.11%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 29.69% 23.11% 23.12% 27.66% 31.32% 27.82% 29.18% 33.41% 35.54% 32.48% 34.35%
Debt to EBITDA		 3.25 3.49 4.76 3.79 3.94 4.42 4.56 3.94 3.97 5.19 4.71
Net Debt to EBITDA		 3.03 3.44 4.66 3.67 3.58 3.86 3.80 3.26 3.22 4.16 3.54
Long-Term Debt to EBITDA		 2.92 3.01 4.56 3.51 3.89 4.38 4.53 3.84 2.95 4.29 4.03
Debt to NOPAT		 6.94 7.88 6.34 7.32 8.12 8.37 8.55 7.92 7.45 10.13 10.41
Net Debt to NOPAT		 6.48 7.75 6.21 7.09 7.38 7.31 7.13 6.56 6.05 8.11 7.82
Long-Term Debt to NOPAT		 6.24 6.78 6.07 6.78 8.01 8.29 8.50 7.73 5.54 8.37 8.90
Altman Z-Score		 2.58 2.50 2.22 2.33 2.35 2.09 2.02 2.41 2.14 1.98 1.87
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.34 1.12 1.35 1.20 1.38 1.51 1.52 1.48 1.02 1.12 1.22
Quick Ratio		 0.49 0.36 0.53 0.54 0.70 0.86 0.89 0.86 0.54 0.63 0.68
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 237 245 -852 461 325 -642 -186 599 345 -222 181
Operating Cash Flow to CapEx		 142.03% 205.61% 223.45% 265.23% 219.69% 268.76% 242.67% 352.34% 214.43% 283.10% 245.69%
Free Cash Flow to Firm to Interest Expense		 3.54 3.61 -7.26 3.88 3.03 -6.10 -1.70 4.69 1.99 -1.33 0.95
Operating Cash Flow to Interest Expense		 5.02 5.82 3.32 4.26 4.73 5.72 5.07 5.86 2.78 4.31 3.85
Operating Cash Flow Less CapEx to Interest Expense		 1.48 2.99 1.84 2.66 2.57 3.59 2.98 4.19 1.49 2.79 2.29
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.16 1.14 1.05 0.96 0.94 0.86 0.80 0.85 0.80 0.72 0.72
Accounts Receivable Turnover		 12.72 12.69 11.01 9.21 8.84 8.75 8.53 9.36 9.52 9.81 10.95
Inventory Turnover		 5.45 5.04 5.22 5.54 5.96 6.19 6.45 6.84 5.84 5.18 5.31
Fixed Asset Turnover		 3.44 3.17 3.09 2.96 0.00 0.00 0.00 3.27 3.08 2.76 2.78
Accounts Payable Turnover		 7.12 6.32 5.93 5.48 5.25 5.30 4.92 5.09 4.87 4.43 4.51
Days Sales Outstanding (DSO)		 28.69 28.75 33.15 39.63 41.31 41.70 42.78 38.98 38.32 37.21 33.32
Days Inventory Outstanding (DIO)		 66.91 72.45 69.94 65.84 61.27 58.99 56.62 53.36 62.48 70.43 68.71
Days Payable Outstanding (DPO)		 51.23 57.79 61.50 66.63 69.58 68.85 74.24 71.70 74.89 82.43 80.87
Cash Conversion Cycle (CCC)		 44.38 43.42 41.59 38.84 33.00 31.84 25.16 20.63 25.91 25.20 21.16
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,053 2,006 3,260 3,113 3,064 4,095 4,724 4,558 4,673 5,304 5,540
Invested Capital Turnover		 1.83 1.78 1.55 1.40 1.45 1.38 1.29 1.38 1.30 1.17 1.20
Increase / (Decrease) in Invested Capital		 -19 -46 1,254 -147 -49 1,031 630 -166 115 630 237
Enterprise Value (EV)		 2,853 2,926 5,443 4,643 5,265 6,739 7,716 8,372 7,530 8,873 7,532
Market Capitalization		 1,440 1,389 2,950 2,411 3,224 3,897 4,555 5,532 4,746 5,559 4,266
Book Value per Share		 $10.58 $7.78 $6.94 $7.97 $9.24 $11.33 $14.15 $15.61 $17.74 $18.63 $21.52
Tangible Book Value per Share		 ($2.79) ($5.24) ($7.45) ($5.88) ($4.27) ($10.18) ($11.83) ($9.36) ($7.98) ($11.20) ($10.53)
Total Capital		 2,153 2,031 3,313 3,186 3,268 4,504 5,356 5,144 5,316 6,126 6,621
Total Debt		 1,514 1,562 2,547 2,305 2,244 3,251 3,793 3,425 3,427 4,137 4,347
Total Long-Term Debt		 1,361 1,344 2,439 2,134 2,215 3,223 3,773 3,345 2,546 3,420 3,715
Net Debt		 1,414 1,537 2,494 2,232 2,041 2,842 3,162 2,840 2,784 3,314 3,266
Capital Expenditures (CapEx)		 236 192 174 191 231 224 229 212 225 255 297
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 316 293 389 308 214 226 176 189 275 169 91
Debt-free Net Working Capital (DFNWC)		 416 317 442 381 418 636 808 775 917 992 1,172
Net Working Capital (NWC)		 264 100 334 211 388 608 787 695 37 275 540
Net Nonoperating Expense (NNE)		 46 45 132 91 83 80 85 92 134 132 129
Net Nonoperating Obligations (NNO)		 1,414 1,537 2,494 2,232 2,041 2,842 3,162 2,840 2,784 3,314 3,266
Total Depreciation and Amortization (D&A)		 146 147 178 196 210 224 256 268 269 281 325
Debt-free, Cash-free Net Working Capital to Revenue		 8.41% 8.10% 9.51% 6.93% 4.77% 4.59% 3.10% 2.95% 4.58% 2.89% 1.40%
Debt-free Net Working Capital to Revenue		 11.06% 8.79% 10.82% 8.57% 9.31% 12.91% 14.23% 12.09% 15.32% 16.95% 18.07%
Net Working Capital to Revenue		 7.02% 2.78% 8.16% 4.74% 8.65% 12.34% 13.87% 10.84% 0.62% 4.70% 8.33%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.83 $2.56 $2.44 $2.03 $1.75 $2.79 $3.25 $3.09 $3.00 $2.59 $2.71
Adjusted Weighted Average Basic Shares Outstanding		 60.39M 55.05M 110.39M 110.43M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Adjusted Diluted Earnings per Share		 $2.81 $2.55 $2.42 $2.01 $1.74 $2.77 $3.23 $3.07 $2.98 $2.58 $2.70
Adjusted Weighted Average Diluted Shares Outstanding		 60.39M 55.05M 110.39M 110.43M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 60.39M 55.05M 110.39M 110.43M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Normalized Net Operating Profit after Tax (NOPAT)		 228 193 231 291 306 371 416 453 470 455 459
Normalized NOPAT Margin		 6.05% 5.34% 5.64% 6.55% 6.81% 7.55% 7.33% 7.07% 7.84% 7.77% 7.07%
Pre Tax Income Margin		 6.72% 6.42% 5.86% 6.59% 5.62% 8.27% 8.21% 7.40% 7.05% 5.94% 6.30%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.78 4.42 3.04 3.47 3.35 4.87 5.25 4.71 3.44 3.08 3.16
NOPAT to Interest Expense		 3.26 2.92 3.42 2.65 2.57 3.69 4.04 3.39 2.65 2.44 2.20
EBIT Less CapEx to Interest Expense		 1.25 1.59 1.56 1.86 1.20 2.74 3.16 3.05 2.14 1.55 1.59
NOPAT Less CapEx to Interest Expense		 -0.27 0.09 1.94 1.04 0.42 1.56 1.95 1.72 1.35 0.92 0.64
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 23.05% 26.66% 15.02% 19.89% 26.23% 17.38% 17.40% 21.11% 24.20% 29.69% 29.74%
Augmented Payout Ratio		 123.40% 209.72% 16.55% 23.38% 40.47% 31.02% 19.79% 34.35% 80.65% 33.06% 55.71%

Quarterly Metrics And Ratios for Silgan

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 105,441,971.00 105,679,758.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 105,441,971.00 105,679,758.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.60 0.72
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -7.92% -7.14% -3.18% -3.22% 5.30% 11.36% 11.42% 15.11% 4.07% 6.45% 6.76%
EBITDA Growth		 36.58% -9.07% -1.53% -9.73% -10.86% 17.73% 17.25% 20.17% 6.25% 0.87% -3.48%
EBIT Growth		 55.43% -14.87% -1.49% -13.81% -25.28% 16.85% 18.10% 18.75% 7.32% -3.03% -9.84%
NOPAT Growth		 126.65% -15.71% -8.10% -8.73% -11.57% 18.01% 16.03% 12.66% -61.34% -6.52% -12.79%
Net Income Growth		 161.96% -23.41% -3.54% -9.55% -30.06% 23.20% 16.88% 13.23% -59.60% -7.24% -14.83%
EPS Growth		 160.87% -20.00% 0.00% -8.82% -30.00% 21.15% 16.90% 13.98% -57.14% -4.76% -13.25%
Operating Cash Flow Growth		 24.56% 13.29% 111.61% 45.12% -13.25% -24.75% -1,159.72% 8.90% 38.26% -17.00% 12.27%
Free Cash Flow Firm Growth		 -108.58% 71.14% 259.23% 229.36% -2,931.56% -1,736.09% -469.19% -464.89% 62.59% 88.11% 116.03%
Invested Capital Growth		 2.53% 0.67% -4.09% -3.37% 13.49% 16.22% 25.13% 24.34% 4.47% 2.94% -1.37%
Revenue Q/Q Growth		 -25.68% -1.72% 4.88% 26.33% -19.14% 3.93% 4.94% 30.51% -26.89% 6.31% 5.25%
EBITDA Q/Q Growth		 -25.60% -4.83% 16.27% 12.77% -26.53% 22.22% 15.80% 15.58% -35.05% 16.03% 10.81%
EBIT Q/Q Growth		 -35.02% -11.42% 26.97% 17.93% -43.67% 38.53% 28.33% 18.58% -49.09% 25.18% 19.31%
NOPAT Q/Q Growth		 -33.55% -13.20% 27.34% 24.26% -35.62% 15.83% 25.20% 20.66% -77.90% 180.06% 16.81%
Net Income Q/Q Growth		 -41.75% -14.38% 37.95% 31.48% -54.96% 50.81% 30.87% 27.38% -83.93% 246.29% 20.18%
EPS Q/Q Growth		 -41.18% -13.33% 36.54% 30.99% -54.84% 50.00% 31.75% 27.71% -83.02% 233.33% 20.00%
Operating Cash Flow Q/Q Growth		 400.05% -150.79% 103.81% 1,397.94% 198.94% -173.03% 67.60% 253.93% 279.54% -161.80% 75.70%
Free Cash Flow Firm Q/Q Growth		 92.86% 368.11% 615.74% -5.64% -267.42% -44.69% -61.51% 6.74% 82.83% 54.00% 317.62%
Invested Capital Q/Q Growth		 -17.80% 17.08% 1.61% -1.19% -3.46% 19.90% 9.40% -1.82% -18.89% 18.14% 4.83%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 16.31% 16.97% 18.53% 16.81% 16.94% 18.44% 19.43% 16.29% 17.21% 17.02% 17.94%
EBITDA Margin		 14.47% 13.63% 15.11% 13.49% 12.25% 14.41% 15.90% 14.08% 12.51% 13.65% 14.37%
Operating Margin		 9.41% 8.48% 10.27% 9.59% 6.68% 8.90% 10.88% 9.89% 6.89% 8.11% 9.19%
EBIT Margin		 9.41% 8.48% 10.27% 9.59% 6.68% 8.90% 10.88% 9.89% 6.89% 8.11% 9.19%
Profit (Net Income) Margin		 4.81% 4.19% 5.51% 5.73% 3.19% 4.63% 5.78% 5.64% 1.24% 4.04% 4.61%
Tax Burden Percent		 77.04% 75.49% 75.71% 79.78% 92.59% 77.57% 74.85% 76.20% 34.10% 74.92% 72.89%
Interest Burden Percent		 66.31% 65.41% 70.86% 74.97% 51.65% 67.12% 70.93% 74.84% 52.79% 66.47% 68.81%
Effective Tax Rate		 22.96% 24.51% 24.29% 20.22% 8.82% 23.76% 25.62% 24.32% 67.15% 26.51% 28.05%
Return on Invested Capital (ROIC)		 9.41% 6.91% 8.00% 7.91% 7.15% 6.89% 7.97% 7.81% 2.70% 6.08% 6.40%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.24% 6.11% 7.17% 7.00% 5.81% 6.08% 7.12% 6.88% 2.25% 5.37% 5.68%
Return on Net Nonoperating Assets (RNNOA)		 12.85% 11.98% 14.23% 13.41% 9.13% 11.99% 14.32% 12.72% 3.47% 10.36% 11.38%
Return on Equity (ROE)		 22.26% 18.90% 22.23% 21.32% 16.27% 18.87% 22.29% 20.52% 6.17% 16.44% 17.78%
Cash Return on Invested Capital (CROIC)		 7.47% 7.48% 11.84% 10.99% -4.45% -7.84% -15.28% -14.28% 3.33% 3.48% 7.09%
Operating Return on Assets (OROA)		 7.54% 6.47% 7.69% 7.13% 4.83% 6.54% 7.84% 7.37% 4.97% 5.90% 6.46%
Return on Assets (ROA)		 3.85% 3.19% 4.12% 4.26% 2.31% 3.41% 4.16% 4.20% 0.89% 2.94% 3.24%
Return on Common Equity (ROCE)		 22.26% 18.90% 22.23% 21.32% 16.27% 18.87% 22.29% 20.52% 6.17% 16.44% 17.78%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 16.27% 15.84% 14.40% 0.00% 13.88% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 97 84 107 133 86 100 125 150 33 93 109
NOPAT Margin		 7.25% 6.40% 7.77% 7.65% 6.09% 6.79% 8.10% 7.48% 2.26% 5.96% 6.61%
Net Nonoperating Expense Percent (NNEP)		 1.16% 0.81% 0.83% 0.91% 1.34% 0.80% 0.85% 0.93% 0.46% 0.71% 0.71%
Return On Investment Capital (ROIC_SIMPLE)		 1.83% - - - 1.40% 1.48% 1.71% 2.08% 0.50% 1.33% 1.51%
Cost of Revenue to Revenue		 83.69% 83.03% 81.47% 83.19% 83.06% 81.56% 80.57% 83.71% 82.79% 82.98% 82.06%
SG&A Expenses to Revenue		 7.21% 7.63% 7.80% 6.10% 8.77% 8.80% 7.92% 6.08% 8.14% 8.40% 7.72%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 6.90% 8.49% 8.26% 7.22% 10.26% 9.54% 8.55% 6.40% 10.32% 8.91% 8.75%
Earnings before Interest and Taxes (EBIT)		 126 112 142 167 94 131 168 199 101 127 151
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 194 179 209 235 173 211 245 283 184 213 236
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.51 2.71 2.34 2.73 2.79 2.62 2.61 2.03 1.88 1.76 2.06
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.79 0.88 0.77 0.97 0.95 0.91 0.94 0.72 0.66 0.62 0.73
Price to Earnings (P/E)		 14.56 16.66 14.76 18.96 20.11 18.88 19.19 14.60 14.79 14.43 18.14
Dividend Yield		 1.62% 1.51% 1.75% 1.43% 1.46% 1.51% 1.44% 1.84% 1.98% 2.09% 1.77%
Earnings Yield		 6.87% 6.00% 6.78% 5.28% 4.97% 5.30% 5.21% 6.85% 6.76% 6.93% 5.51%
Enterprise Value to Invested Capital (EV/IC)		 1.61 1.59 1.47 1.65 1.67 1.53 1.51 1.34 1.36 1.27 1.37
Enterprise Value to Revenue (EV/Rev)		 1.26 1.48 1.39 1.56 1.52 1.62 1.71 1.43 1.16 1.26 1.40
Enterprise Value to EBITDA (EV/EBITDA)		 8.71 10.31 9.66 11.06 11.14 11.75 12.19 10.05 8.16 9.00 10.25
Enterprise Value to EBIT (EV/EBIT)		 12.65 15.15 14.20 16.54 17.23 18.23 18.82 15.50 12.60 14.00 16.25
Enterprise Value to NOPAT (EV/NOPAT)		 16.38 19.64 18.73 21.40 21.72 22.98 23.90 20.05 18.04 20.23 23.78
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.60 15.40 10.61 10.46 12.29 16.60 30.62 24.64 10.32 13.55 14.64
Enterprise Value to Free Cash Flow (EV/FCFF)		 21.85 21.38 12.12 14.72 0.00 0.00 0.00 0.00 41.71 37.08 19.16
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.81 2.04 2.03 1.85 2.08 2.22 2.27 2.18 1.91 2.01 2.03
Long-Term Debt to Equity		 1.35 1.33 1.31 1.24 1.72 1.67 1.40 1.68 1.63 1.58 1.54
Financial Leverage		 1.56 1.96 1.98 1.91 1.57 1.97 2.01 1.85 1.54 1.93 2.00
Leverage Ratio		 4.15 4.19 4.10 4.06 4.18 4.10 4.12 3.99 4.22 4.11 4.13
Compound Leverage Factor		 2.75 2.74 2.91 3.04 2.16 2.75 2.92 2.98 2.23 2.73 2.84
Debt to Total Capital		 64.46% 67.13% 67.02% 64.96% 67.52% 68.96% 69.45% 68.52% 65.65% 66.76% 67.01%
Short-Term Debt to Total Capital		 16.56% 23.28% 23.85% 21.40% 11.70% 17.06% 26.63% 15.72% 9.54% 14.16% 16.33%
Long-Term Debt to Total Capital		 47.90% 43.85% 43.17% 43.56% 55.82% 51.90% 42.82% 52.80% 56.11% 52.60% 50.68%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 35.54% 32.87% 32.98% 35.04% 32.48% 31.04% 30.55% 31.48% 34.35% 33.24% 32.99%
Debt to EBITDA		 3.97 4.59 4.66 4.66 5.19 5.59 5.85 5.43 4.71 5.04 5.28
Net Debt to EBITDA		 3.22 4.22 4.30 4.21 4.16 5.16 5.48 5.00 3.54 4.57 4.89
Long-Term Debt to EBITDA		 2.95 3.00 3.00 3.12 4.29 4.21 3.60 4.18 4.03 3.97 3.99
Debt to NOPAT		 7.45 8.73 9.03 9.01 10.13 10.93 11.47 10.83 10.41 11.34 12.25
Net Debt to NOPAT		 6.05 8.04 8.34 8.14 8.11 10.09 10.75 9.98 7.82 10.28 11.36
Long-Term Debt to NOPAT		 5.54 5.71 5.82 6.04 8.37 8.22 7.07 8.35 8.90 8.93 9.26
Altman Z-Score		 1.94 1.98 1.91 2.05 1.82 1.82 1.70 1.74 1.69 1.73 1.78
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.02 1.04 1.06 1.09 1.12 1.14 0.96 1.27 1.22 1.26 1.27
Quick Ratio		 0.54 0.55 0.57 0.68 0.63 0.60 0.50 0.77 0.68 0.68 0.70
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -18 48 345 325 -544 -788 -1,272 -1,187 -204 -94 204
Operating Cash Flow to CapEx		 2,026.37% -752.87% 37.52% 518.63% 1,414.07% -824.65% -350.01% 426.67% 1,821.83% -994.78% -313.57%
Free Cash Flow to Firm to Interest Expense		 -0.42 1.25 8.34 7.77 -11.95 -18.35 -26.13 -23.74 -4.27 -2.21 4.33
Operating Cash Flow to Interest Expense		 25.38 -14.17 0.51 7.48 20.54 -15.92 -4.55 6.82 27.10 -18.84 -4.12
Operating Cash Flow Less CapEx to Interest Expense		 24.13 -16.06 -0.84 6.03 19.08 -17.85 -5.85 5.22 25.61 -20.73 -5.44
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.80 0.76 0.75 0.74 0.72 0.73 0.72 0.75 0.72 0.73 0.70
Accounts Receivable Turnover		 9.52 6.26 5.50 4.62 9.81 6.13 5.36 4.74 10.95 6.06 4.96
Inventory Turnover		 5.84 4.88 4.30 5.64 5.18 4.91 4.47 5.87 5.31 4.98 4.45
Fixed Asset Turnover		 3.08 3.04 3.02 2.99 2.76 2.83 2.86 2.95 2.78 2.82 2.83
Accounts Payable Turnover		 4.87 7.40 6.89 7.20 4.43 7.35 7.15 6.91 4.51 6.99 6.72
Days Sales Outstanding (DSO)		 38.32 58.35 66.37 79.08 37.21 59.54 68.08 77.06 33.32 60.25 73.66
Days Inventory Outstanding (DIO)		 62.48 74.81 84.80 64.72 70.43 74.26 81.65 62.20 68.71 73.36 82.03
Days Payable Outstanding (DPO)		 74.89 49.31 52.97 50.67 82.43 49.69 51.05 52.79 80.87 52.20 54.32
Cash Conversion Cycle (CCC)		 25.91 83.85 98.20 93.13 25.20 84.11 98.68 86.47 21.16 81.42 101.36
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,673 5,472 5,560 5,494 5,304 6,359 6,957 6,830 5,540 6,546 6,862
Invested Capital Turnover		 1.30 1.08 1.03 1.03 1.17 1.02 0.98 1.04 1.20 1.02 0.97
Increase / (Decrease) in Invested Capital		 115 36 -237 -192 630 887 1,397 1,337 237 187 -95
Enterprise Value (EV)		 7,530 8,723 8,146 9,045 8,873 9,735 10,532 9,160 7,532 8,316 9,385
Market Capitalization		 4,746 5,151 4,520 5,606 5,559 5,459 5,797 4,602 4,266 4,091 4,902
Book Value per Share		 $17.74 $17.84 $18.11 $19.24 $18.63 $19.51 $20.77 $21.24 $21.52 $22.01 $22.51
Tangible Book Value per Share		 ($7.98) ($7.51) ($6.92) ($6.10) ($11.20) ($11.05) ($10.93) ($10.29) ($10.53) ($9.71) ($8.88)
Total Capital		 5,316 5,780 5,863 5,862 6,126 6,712 7,274 7,220 6,621 6,981 7,213
Total Debt		 3,427 3,880 3,929 3,808 4,137 4,629 5,052 4,947 4,347 4,660 4,834
Total Long-Term Debt		 2,546 2,535 2,531 2,554 3,420 3,483 3,115 3,812 3,715 3,672 3,656
Net Debt		 2,784 3,572 3,626 3,440 3,314 4,276 4,735 4,558 3,266 4,225 4,482
Capital Expenditures (CapEx)		 53 73 56 60 66 83 63 80 71 80 62
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 275 1,124 1,238 1,100 169 1,104 1,494 1,407 91 1,162 1,531
Debt-free Net Working Capital (DFNWC)		 917 1,433 1,541 1,468 992 1,457 1,812 1,796 1,172 1,597 1,882
Net Working Capital (NWC)		 37 87 143 214 275 312 -126 661 540 609 704
Net Nonoperating Expense (NNE)		 33 29 31 33 41 32 36 37 15 30 33
Net Nonoperating Obligations (NNO)		 2,784 3,572 3,626 3,440 3,314 4,276 4,735 4,558 3,266 4,225 4,482
Total Depreciation and Amortization (D&A)		 68 68 67 68 79 81 77 84 83 87 85
Debt-free, Cash-free Net Working Capital to Revenue		 4.58% 19.09% 21.19% 19.01% 2.89% 18.39% 24.25% 21.90% 1.40% 17.66% 22.91%
Debt-free Net Working Capital to Revenue		 15.32% 24.34% 26.38% 25.38% 16.95% 24.27% 29.40% 27.96% 18.07% 24.28% 28.17%
Net Working Capital to Revenue		 0.62% 1.48% 2.44% 3.70% 4.70% 5.20% -2.04% 10.29% 8.33% 9.26% 10.54%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.61 $0.52 $0.71 $0.94 $0.42 $0.64 $0.83 $1.06 $0.18 $0.60 $0.72
Adjusted Weighted Average Basic Shares Outstanding		 106.50M 106.65M 106.84M 106.85M 106.79M 106.92M 107.05M 106.62M 105.44M 105.59M 105.68M
Adjusted Diluted Earnings per Share		 $0.60 $0.52 $0.71 $0.93 $0.42 $0.63 $0.83 $1.06 $0.18 $0.60 $0.72
Adjusted Weighted Average Diluted Shares Outstanding		 106.50M 107.05M 107.02M 107.14M 106.79M 107.34M 107.25M 106.80M 105.44M 105.86M 105.68M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 106.50M 106.78M 106.78M 106.79M 106.79M 106.99M 106.99M 105.67M 105.44M 105.68M 105.68M
Normalized Net Operating Profit after Tax (NOPAT)		 94 93 112 149 105 108 132 155 93 99 121
Normalized NOPAT Margin		 7.01% 7.05% 8.13% 8.54% 7.44% 7.35% 8.57% 7.73% 6.35% 6.34% 7.36%
Pre Tax Income Margin		 6.24% 5.55% 7.28% 7.19% 3.45% 5.97% 7.72% 7.40% 3.64% 5.39% 6.32%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 2.97 2.89 3.43 4.00 2.07 3.04 3.44 3.97 2.12 2.98 3.21
NOPAT to Interest Expense		 2.29 2.18 2.60 3.19 1.89 2.32 2.56 3.01 0.70 2.19 2.31
EBIT Less CapEx to Interest Expense		 1.72 1.01 2.08 2.55 0.62 1.11 2.14 2.38 0.63 1.09 1.89
NOPAT Less CapEx to Interest Expense		 1.03 0.30 1.25 1.75 0.43 0.39 1.26 1.41 -0.79 0.30 0.99
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 24.20% 25.71% 26.09% 27.37% 29.69% 28.65% 27.80% 26.99% 29.74% 30.58% 32.36%
Augmented Payout Ratio		 80.65% 83.38% 78.57% 30.00% 33.06% 31.60% 30.60% 48.47% 55.71% 57.34% 60.44%

Financials Breakdown Chart

Key Financial Trends

Silgan Holdings (NYSE: SLGN) showed a notable rebound in Q1 2026 after a softer Q4 2025, but the balance sheet and cash flow trends still point to a highly leveraged company with uneven cash generation.

For Q1 2026, revenue rose to $1.56 billion from $1.47 billion in Q4 2025, and net income improved sharply to $63.0 million from $18.2 million. Gross margin also improved modestly, helped by better operating profitability and lower operating expense intensity versus the prior quarter.

  • Q1 2026 revenue increased quarter over quarter to $1.56 billion, showing better top-line momentum.
  • Net income rose to $63.0 million from $18.2 million in Q4 2025, a strong sequential improvement.
  • Operating income improved to $126.6 million, up from $101.1 million in Q4 2025.
  • Gross profit increased to $265.8 million, reflecting improved spread between revenue and cost of goods sold.
  • Cash on hand increased to $435.4 million from $389.2 million at Q3 2025, providing some near-term liquidity support.
  • Quarterly basic EPS improved to $0.60 from $0.18 in Q4 2025.
  • Silgan continues to generate strong earnings before non-cash items, with depreciation and amortization still a meaningful add-back to reported cash flow.
  • The company continues to pay a dividend, which signals shareholder returns but also consumes cash.
  • Operating cash flow was negative $799.6 million in Q1 2026, pressured by a very large working-capital swing.
  • Total debt remains elevated at about $4.66 billion combined short-term and long-term debt, leaving the balance sheet leveraged.

Looking at the longer trend, Silgan’s profitability has improved from the weaker periods in 2022 and early 2023. Quarterly revenue has generally stayed in the $1.3 billion to $2.0 billion range, while net income has been positive across the periods shown. That said, earnings have been volatile, especially when restructuring charges and working-capital changes spike.

One of the biggest concerns is cash flow consistency. In several quarters, Silgan generated solid operating cash flow, but in Q1 2025 and Q1 2026 operating cash flow turned sharply negative because of large changes in operating assets and liabilities. This suggests reported earnings have not always converted cleanly into cash.

The balance sheet also shows a persistent leverage profile. As of Q1 2026, total liabilities were $7.00 billion against equity of $2.32 billion. Goodwill and intangible assets remain large, so a meaningful portion of assets is tied to acquisitions rather than hard assets.

Bottom line: Silgan’s latest quarter looks better on earnings and revenue, but investors should watch cash conversion and debt levels closely. The business appears profitable and reasonably stable operationally, but leverage and working-capital volatility remain key risks.

08/23/26 07:51 AM ETAI Generated. May Contain Errors.

Silgan Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Silgan's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Silgan's net income appears to be on an upward trend, with a most recent value of $288.40 million in 2025, rising from $172.41 million in 2015. The previous period was $276.38 million in 2024. Find out what analysts predict for Silgan in the coming months.

Silgan's total operating income in 2025 was $597.87 million, based on the following breakdown:
  • Total Gross Profit: $1.15 billion
  • Total Operating Expenses: $551.56 million

Over the last 10 years, Silgan's total revenue changed from $3.76 billion in 2015 to $6.48 billion in 2025, a change of 72.2%.

Silgan's total liabilities were at $7.12 billion at the end of 2025, a 8.0% increase from 2024, and a 178.9% increase since 2015.

In the past 10 years, Silgan's cash and equivalents has ranged from $24.69 million in 2016 to $1.08 billion in 2025, and is currently $1.08 billion as of their latest financial filing in 2025.

Over the last 10 years, Silgan's book value per share changed from 10.58 in 2015 to 21.52 in 2025, a change of 103.4%.


Related Companies

Financial statements for NYSE:SLGN last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel